These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 2018841)
1. Iron mobilization from myocardial cells by 3-hydroxypyridin-4-one chelators: studies in rat heart cells in culture. Hershko C; Link G; Pinson A; Peter HH; Dobbin P; Hider RC Blood; 1991 May; 77(9):2049-53. PubMed ID: 2018841 [TBL] [Abstract][Full Text] [Related]
2. Iron mobilization from hepatocyte monolayer cultures by chelators: the importance of membrane permeability and the iron-binding constant. Porter JB; Gyparaki M; Burke LC; Huehns ER; Sarpong P; Saez V; Hider RC Blood; 1988 Nov; 72(5):1497-503. PubMed ID: 3179437 [TBL] [Abstract][Full Text] [Related]
3. Origin and fate of iron mobilized by the 3-hydroxypyridin-4-one oral chelators: studies in hypertransfused rats by selective radioiron probes of reticuloendothelial and hepatocellular iron stores. Zevin S; Link G; Grady RW; Hider RC; Peter HH; Hershko C Blood; 1992 Jan; 79(1):248-53. PubMed ID: 1728313 [TBL] [Abstract][Full Text] [Related]
4. Ability of the orally effective iron chelators dimethyl- and diethyl-hydroxypyrid-4-one and of deferoxamine to restore sarcolemmal thiolic enzyme activity in iron-loaded heart cells. Link G; Pinson A; Hershko C Blood; 1994 May; 83(9):2692-7. PubMed ID: 8167347 [TBL] [Abstract][Full Text] [Related]
5. The effect of N-alkyl modification on the antimalarial activity of 3-hydroxypyridin-4-one oral iron chelators. Hershko C; Theanacho EN; Spira DT; Peter HH; Dobbin P; Hider RC Blood; 1991 Feb; 77(3):637-43. PubMed ID: 1991172 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of iron toxicity in rat and human hepatocyte cultures by the hydroxypyridin-4-ones CP20 and CP94. Chenoufi N; Hubert N; Loréal O; Morel I; Pasdeloup N; Cillard J; Brissot P; Lescoat G J Hepatol; 1995 Aug; 23(2):166-73. PubMed ID: 7499788 [TBL] [Abstract][Full Text] [Related]
7. Contrasting interspecies efficacy and toxicology of 1,2-diethyl-3-hydroxypyridin-4-one, CP94, relates to differing metabolism of the iron chelating site. Porter JB; Abeysinghe RD; Hoyes KP; Barra C; Huehns ER; Brooks PN; Blackwell MP; Araneta M; Brittenham G; Singh S Br J Haematol; 1993 Sep; 85(1):159-68. PubMed ID: 8251385 [TBL] [Abstract][Full Text] [Related]
8. Antioxidant and free radical scavenging activities of the iron chelators pyoverdin and hydroxypyrid-4-ones in iron-loaded hepatocyte cultures: comparison of their mechanism of protection with that of desferrioxamine. Morel I; Cillard J; Lescoat G; Sergent O; Pasdeloup N; Ocaktan AZ; Abdallah MA; Brissot P; Cillard P Free Radic Biol Med; 1992 Nov; 13(5):499-508. PubMed ID: 1334028 [TBL] [Abstract][Full Text] [Related]
9. Influence of iron chelators, 1,2-dialkyl-3-hydroxypyridin-4-ones, on the lipid peroxidation and glutathione level in the liver of mice. Eybl V; Caisová D; Koutenský J; Kontoghiorghes GJ Arch Toxicol Suppl; 1991; 14():185-7. PubMed ID: 1805729 [No Abstract] [Full Text] [Related]
10. Chelator-facilitated removal of iron from transferrin: relevance to combined chelation therapy. Devanur LD; Evans RW; Evans PJ; Hider RC Biochem J; 2008 Jan; 409(2):439-47. PubMed ID: 17919118 [TBL] [Abstract][Full Text] [Related]
11. Synergistic intracellular iron chelation combinations: mechanisms and conditions for optimizing iron mobilization. Vlachodimitropoulou Koumoutsea E; Garbowski M; Porter J Br J Haematol; 2015 Sep; 170(6):874-83. PubMed ID: 26033030 [TBL] [Abstract][Full Text] [Related]
12. The iron chelator deferoxamine prevents cisplatin-induced lipid peroxidation in rat kidney cortical slices. Kameyama Y; Gemba M Jpn J Pharmacol; 1991 Oct; 57(2):259-62. PubMed ID: 1812305 [TBL] [Abstract][Full Text] [Related]
13. Multidentate pyridinones inhibit the metabolism of nontransferrin-bound iron by hepatocytes and hepatoma cells. Chua AC; Ingram HA; Raymond KN; Baker E Eur J Biochem; 2003 Apr; 270(8):1689-98. PubMed ID: 12694182 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of 2-amido-3-hydroxypyridin-4(1H)-ones: novel iron chelators with enhanced pFe3+ values. Liu ZD; Piyamongkol S; Liu DY; Khodr HH; Lu SL; Hider RC Bioorg Med Chem; 2001 Mar; 9(3):563-73. PubMed ID: 11310590 [TBL] [Abstract][Full Text] [Related]
15. Cellular uptake and release of two contrasting iron chelators. Cable H; Lloyd JB J Pharm Pharmacol; 1999 Feb; 51(2):131-4. PubMed ID: 10217310 [TBL] [Abstract][Full Text] [Related]
16. A comparison of the iron-clearing properties of 1,2-dimethyl-3-hydroxypyrid-4-one, 1,2-diethyl-3-hydroxypyrid-4-one, and deferoxamine. Bergeron RJ; Streiff RR; Wiegand J; Luchetta G; Creary EA; Peter HH Blood; 1992 Apr; 79(7):1882-90. PubMed ID: 1558978 [TBL] [Abstract][Full Text] [Related]
17. Subcellular distribution of desferrioxamine and hydroxypyridin-4-one chelators in K562 cells affects chelation of intracellular iron pools. Hoyes KP; Porter JB Br J Haematol; 1993 Oct; 85(2):393-400. PubMed ID: 8280612 [TBL] [Abstract][Full Text] [Related]
18. Biliary and urinary metabolic profiles of 1,2-diethyl-3-hydroxypyridin-4-one (CP94) in the rat. Lu SL; Gosriwatana I; Liu DY; Liu ZD; Mallet AI; Hider RC Drug Metab Dispos; 2000 Aug; 28(8):873-9. PubMed ID: 10901694 [TBL] [Abstract][Full Text] [Related]
19. Characterization of two isomeric beta-d-glucosiduronic acids derived from 1,2-diethyl-3-hydroxypyridin-4-one (CP94) in rat liver homogenate incubates. Liu DY; Liu ZD; Piyamongkol S; Lu SL; Hider RC J Pharm Pharmacol; 2002 Jul; 54(7):951-7. PubMed ID: 12162714 [TBL] [Abstract][Full Text] [Related]
20. In vivo and in vitro effects of 3-hydroxypyridin-4-one chelators on murine hemopoiesis. Hoyes KP; Jones HM; Abeysinghe RD; Hider RC; Porter JB Exp Hematol; 1993 Jan; 21(1):86-92. PubMed ID: 8417963 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]